{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:03:19Z","timestamp":1780362199534,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010346","name":"Else og Mogens Wedell Wedellsborgs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009908","name":"Grosserer L. F. Foghts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009908","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the memorial fund of lawyer Valdemar Beck and his wife Marie Beck"},{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and objectives<\/jats:title>\n                <jats:p>Primary hypokalemic periodic paralysis (HypoPP) is an inherited channelopathy most commonly caused by mutations in <jats:italic>CACNA1S<\/jats:italic>. HypoPP can present with different phenotypes: periodic paralysis (PP), permanent muscle weakness (PW), and mixed weakness (MW) with both periodic and permanent weakness. Little is known about the natural history of HypoPP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this 3-year follow-up study, we used the MRC scale for manual muscle strength testing and whole-body muscle MRI (Mercuri score) to assess disease progression in individuals with HypoPP-causing mutations in <jats:italic>CACNA1S.<\/jats:italic><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 25 men (mean age 43\u00a0years, range 18\u201376\u00a0years) and 12 women (mean age 42\u00a0years, range 18\u201376\u00a0years). Two participants were asymptomatic, 21 had PP, 12\u00a0MW, and two PW. The median number of months between baseline and follow-up was 42 (range 26\u201352). Muscle strength declined in 11 patients during follow-up. Four of the patients with a decline in muscle strength had no attacks of paralysis during follow-up, and two of these patients had never had attacks of paralysis. Fat replacement of muscles increased in 27 patients during follow-up. Eight of the patients with increased fat replacement had no attacks of paralysis during follow-up, and two of these patients had never had attacks of paralysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The study demonstrates that HypoPP can be a progressive myopathy in both patients with and without attacks of paralysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-023-11964-z","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T10:02:52Z","timestamp":1693562572000},"page":"6057-6063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hypokalemic periodic paralysis: a 3-year follow-up study"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-2744","authenticated-orcid":false,"given":"Sonja","family":"Holm-Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Witting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt St\u00e6vnsbo","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dysgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Sloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kannuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefine","family":"de Stricker Borch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuva","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freja","family":"Fornander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sofie","family":"Eisum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"11964_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng0394-267","volume":"6","author":"B Fontaine","year":"1994","unstructured":"Fontaine B, Vale-Santos J, Jurkat-Rott K et al (1994) Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet 6:267\u2013272","journal-title":"Nat Genet"},{"issue":"4","key":"11964_CR2","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1212\/WNL.0000000000009828","volume":"95","author":"S Holm-Yildiz","year":"2020","unstructured":"Holm-Yildiz S, Witting N, Dahlqvist J et al (2020) Permanent muscle weakness in hypokalemic periodic paralysis. Neurology 95(4):e342\u2013e352","journal-title":"Neurology"},{"key":"11964_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1096-8628(19970303)69:1<102::AID-AJMG20>3.0.CO;2-S","volume":"69","author":"A Sillen","year":"1997","unstructured":"Sillen A, S\u00f8rensen T, Kantola I, Friis ML, Gustavson KH, Wadelius C (1997) Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 69:102\u2013106","journal-title":"Am J Med Genet"},{"key":"11964_CR4","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.1073\/pnas.97.17.9549","volume":"97","author":"K Jurkat-Rott","year":"2000","unstructured":"Jurkat-Rott K, Mitrovic N, Hang C et al (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci 97:9549\u20139554","journal-title":"Proc Natl Acad Sci"},{"key":"11964_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0092-8674(94)90135-X","volume":"77","author":"LJ Pt\u00e1\u010dek","year":"1994","unstructured":"Pt\u00e1\u010dek LJ, Tawil R, Griggs RC et al (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863\u2013868","journal-title":"Cell"},{"key":"11964_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10048-021-00673-2","volume":"23","author":"R Brugnoni","year":"2022","unstructured":"Brugnoni R, Canioni E, Filosto M et al (2022) Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes. Neurogenetics 23:19\u201325","journal-title":"Neurogenetics"},{"key":"11964_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.nmd.2018.03.006","volume":"28","author":"BC Stunnenberg","year":"2018","unstructured":"Stunnenberg BC, Raaphorst J, Deenen JCW et al (2018) Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Neuromuscul Disord 28:402\u2013407","journal-title":"Neuromuscul Disord"},{"key":"11964_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0960-8966(96)00401-4","volume":"7","author":"G Fouad","year":"1997","unstructured":"Fouad G, Dalakas M, Servidei S et al (1997) Genotype-phenotype correlations of DHP receptor \u03b11-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 7:33\u201338","journal-title":"Neuromuscul Disord"},{"key":"11964_CR9","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/01.WNL.0000143383.91137.00","volume":"63","author":"TM Miller","year":"2004","unstructured":"Miller TM, Dias Da Silva MR, Miller HA et al (2004) Correlating phenotype and genotype in the periodic paralyses. Neurology 63:1647\u20131655","journal-title":"Neurology"},{"key":"11964_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/practneurol-2017-001677","volume":"18","author":"AJ Chalissery","year":"2018","unstructured":"Chalissery AJ, Munteanu T, Langan Y, Brett F, Redmond J (2018) Diverse phenotype of hypokalaemic periodic paralysis within a family. Pract Neurol 18:60\u201365. https:\/\/doi.org\/10.1136\/practneurol-2017-001677","journal-title":"Pract Neurol"},{"key":"11964_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jocn.2015.06.006","volume":"22","author":"D Basali","year":"2015","unstructured":"Basali D, Prayson RA (2015) Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis. J Clin Neurosci 22:1846\u20131847","journal-title":"J Clin Neurosci"},{"key":"11964_CR12","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1073\/pnas.0811277106","volume":"106","author":"K Jurkat-Rott","year":"2009","unstructured":"Jurkat-Rott K, Weber M-A, Fauler M et al (2009) K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks. Proc Natl Acad Sci 106:4036\u20134041","journal-title":"Proc Natl Acad Sci"},{"key":"11964_CR13","volume-title":"Musculoskeletal assessment. Joint range of motion and manual muscle strength","author":"HM Clarkson","year":"2000","unstructured":"Clarkson HM (2000) Musculoskeletal assessment. Joint range of motion and manual muscle strength. Lippinott Williams & Wilkins, Baltimore"},{"key":"11964_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jmri.20804","volume":"25","author":"E Mercuri","year":"2007","unstructured":"Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007) Muscle MRI in inherited neuromuscular disorders: Past, present, and future. J Magn Reson Imaging 25:433\u2013440","journal-title":"J Magn Reson Imaging"},{"key":"11964_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00008","author":"D Tricarico","year":"2011","unstructured":"Tricarico D, Camerino DC (2011) Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2011.00008","journal-title":"Front Pharmacol"},{"key":"11964_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e31823a0cb6","volume":"77","author":"E Matthews","year":"2011","unstructured":"Matthews E, Portaro S, Ke Q et al (2011) Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology 77:1960\u20131964","journal-title":"Neurology"},{"key":"11964_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0000000000002416","volume":"86","author":"VA Sansone","year":"2016","unstructured":"Sansone VA, Burge J, McDermott MP et al (2016) Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology 86:1408\u20131416","journal-title":"Neurology"},{"key":"11964_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/bjp.2008.42","volume":"154","author":"D Tricarico","year":"2008","unstructured":"Tricarico D, Lovaglio S, Mele A et al (2008) Acetazolamide prevents vacuolar myopathy in skeletal muscle of K +-depleted rats. Br J Pharmacol 154:183\u2013190","journal-title":"Br J Pharmacol"},{"key":"11964_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01212-8","volume":"9","author":"TO Krag","year":"2021","unstructured":"Krag TO, Holm-Yildiz S, Witting N, Vissing J (2021) Autophagy is affected in patients with hypokalemic periodic paralysis: an involvement in vacuolar myopathy? Acta Neuropathol Commun BioMed Cent 9:1\u201316. https:\/\/doi.org\/10.1186\/s40478-021-01212-8","journal-title":"Acta Neuropathol Commun BioMed Cent"},{"key":"11964_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/mus.1070","volume":"24","author":"DM Escolar","year":"2001","unstructured":"Escolar DM, Henricson EK, Mayhew J et al (2001) Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24:787\u2013793","journal-title":"Muscle Nerve"},{"issue":"6","key":"11964_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1191\/0269215505cr873oa","volume":"19","author":"RW Bohannon","year":"2005","unstructured":"Bohannon RW (2005) Manual muscle testing: does it meet the standards of an adequate screening test? Clin Rehabil. 19(6):662\u2013667","journal-title":"Clin Rehabil"},{"key":"11964_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1249\/MSS.0000000000001119","volume":"49","author":"JR Dahlqvist","year":"2017","unstructured":"Dahlqvist JR, Vissing CR, Hedermann G, Thomsen C, Vissing J (2017) Fat replacement of paraspinal muscles with aging in healthy adults. Med Sci Sports Exerc 49:595\u2013601","journal-title":"Med Sci Sports Exerc"},{"key":"11964_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00415-016-8361-3","volume":"264","author":"G Andersen","year":"2017","unstructured":"Andersen G, Dahlqvist JR, Vissing CR, Heje K, Thomsen C, Vissing J (2017) MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients. J Neurol 264:438\u2013447","journal-title":"J Neurol"},{"key":"11964_CR24","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1212\/WNL.0000000000006887","volume":"92","author":"JR Dahlqvist","year":"2019","unstructured":"Dahlqvist JR, Oestergaard ST, Poulsen NS, Thomsen C, Vissing J (2019) Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology 92:e548\u2013e559","journal-title":"Neurology"},{"key":"11964_CR25","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/s41598-023-29759-7","volume":"13","author":"JJ Pedersen","year":"2023","unstructured":"Pedersen JJ, Stemmerik MG, Jacobsen LN et al (2023) Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders. Sci Rep 13:2538","journal-title":"Sci Rep"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11964-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T14:10:32Z","timestamp":1699452632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11964-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["11964"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11964-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Danish National Committee on Health Research Ethics approved the research protocol (approval number H-20057357), and written informed consent was obtained from all participants. The authors declare that no funds, grants, or other supports were received during the preparation of this manuscript. The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard statement"}}]}}